TW363960B - Aryloxycycloalkenyl and aryloxyiminocycloalkenylhydroxyureas - Google Patents
Aryloxycycloalkenyl and aryloxyiminocycloalkenylhydroxyureasInfo
- Publication number
- TW363960B TW363960B TW084111851A TW84111851A TW363960B TW 363960 B TW363960 B TW 363960B TW 084111851 A TW084111851 A TW 084111851A TW 84111851 A TW84111851 A TW 84111851A TW 363960 B TW363960 B TW 363960B
- Authority
- TW
- Taiwan
- Prior art keywords
- alkyl
- hydrogen
- chr1
- haloalkyl
- halo
- Prior art date
Links
- -1 cyano, amino Chemical group 0.000 abstract 5
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 abstract 4
- 229910052739 hydrogen Inorganic materials 0.000 abstract 4
- 239000001257 hydrogen Substances 0.000 abstract 4
- 125000004765 (C1-C4) haloalkyl group Chemical group 0.000 abstract 3
- 125000000229 (C1-C4)alkoxy group Chemical group 0.000 abstract 3
- 101100277337 Arabidopsis thaliana DDM1 gene Proteins 0.000 abstract 3
- 101150113676 chr1 gene Proteins 0.000 abstract 3
- 125000001475 halogen functional group Chemical group 0.000 abstract 3
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 3
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 2
- 125000003282 alkyl amino group Chemical group 0.000 abstract 2
- 125000004414 alkyl thio group Chemical group 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 2
- ZUOUZKKEUPVFJK-UHFFFAOYSA-N diphenyl Chemical compound C1=CC=CC=C1C1=CC=CC=C1 ZUOUZKKEUPVFJK-UHFFFAOYSA-N 0.000 abstract 2
- 150000002431 hydrogen Chemical group 0.000 abstract 2
- 125000004356 hydroxy functional group Chemical group O* 0.000 abstract 2
- 125000004767 (C1-C4) haloalkoxy group Chemical group 0.000 abstract 1
- 229940124125 5 Lipoxygenase inhibitor Drugs 0.000 abstract 1
- 125000002853 C1-C4 hydroxyalkyl group Chemical group 0.000 abstract 1
- 208000024172 Cardiovascular disease Diseases 0.000 abstract 1
- 206010020751 Hypersensitivity Diseases 0.000 abstract 1
- 239000000867 Lipoxygenase Inhibitor Substances 0.000 abstract 1
- 125000005236 alkanoylamino group Chemical group 0.000 abstract 1
- 125000004450 alkenylene group Chemical group 0.000 abstract 1
- 125000004183 alkoxy alkyl group Chemical group 0.000 abstract 1
- 125000005083 alkoxyalkoxy group Chemical group 0.000 abstract 1
- 125000004453 alkoxycarbonyl group Chemical group 0.000 abstract 1
- 125000000217 alkyl group Chemical group 0.000 abstract 1
- 125000002947 alkylene group Chemical group 0.000 abstract 1
- 208000026935 allergic disease Diseases 0.000 abstract 1
- 230000007815 allergy Effects 0.000 abstract 1
- 235000010290 biphenyl Nutrition 0.000 abstract 1
- 239000004305 biphenyl Substances 0.000 abstract 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 abstract 1
- 150000001768 cations Chemical class 0.000 abstract 1
- 125000004093 cyano group Chemical group *C#N 0.000 abstract 1
- 125000000392 cycloalkenyl group Chemical group 0.000 abstract 1
- 239000003937 drug carrier Substances 0.000 abstract 1
- 125000002541 furyl group Chemical group 0.000 abstract 1
- 208000027866 inflammatory disease Diseases 0.000 abstract 1
- 125000001624 naphthyl group Chemical group 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 125000000951 phenoxy group Chemical class [H]C1=C([H])C([H])=C(O*)C([H])=C1[H] 0.000 abstract 1
- 125000003356 phenylsulfanyl group Chemical class [*]SC1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 abstract 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 abstract 1
- 125000004076 pyridyl group Chemical group 0.000 abstract 1
- 125000005493 quinolyl group Chemical group 0.000 abstract 1
- 125000001544 thienyl group Chemical group 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C273/00—Preparation of urea or its derivatives, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
- C07C273/18—Preparation of urea or its derivatives, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups of substituted ureas
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C275/00—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
- C07C275/64—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups singly-bound to oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/17—Amides, e.g. hydroxamic acids having the group >N—C(O)—N< or >N—C(S)—N<, e.g. urea, thiourea, carmustine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Rheumatology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pain & Pain Management (AREA)
- Epidemiology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP9401897 | 1994-11-10 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TW363960B true TW363960B (en) | 1999-07-11 |
Family
ID=14098792
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TW084111851A TW363960B (en) | 1994-11-10 | 1995-11-08 | Aryloxycycloalkenyl and aryloxyiminocycloalkenylhydroxyureas |
Country Status (27)
| Country | Link |
|---|---|
| US (1) | US5798383A (zh) |
| EP (1) | EP0790981B1 (zh) |
| KR (1) | KR0182321B1 (zh) |
| AR (1) | AR002239A1 (zh) |
| AT (1) | ATE184272T1 (zh) |
| AU (1) | AU690354B2 (zh) |
| BR (1) | BR9505130A (zh) |
| CA (1) | CA2205033C (zh) |
| CO (1) | CO4520227A1 (zh) |
| CZ (1) | CZ282832B6 (zh) |
| DE (1) | DE69512080T2 (zh) |
| ES (1) | ES2135066T3 (zh) |
| FI (1) | FI113643B (zh) |
| GR (1) | GR3031378T3 (zh) |
| IL (1) | IL115853A (zh) |
| MX (1) | MX9703485A (zh) |
| MY (1) | MY112595A (zh) |
| NO (1) | NO305362B1 (zh) |
| NZ (1) | NZ280434A (zh) |
| PE (1) | PE49596A1 (zh) |
| PL (1) | PL179023B1 (zh) |
| RU (1) | RU2119479C1 (zh) |
| SG (1) | SG44332A1 (zh) |
| TR (1) | TR199501413A2 (zh) |
| TW (1) | TW363960B (zh) |
| WO (1) | WO1996015106A1 (zh) |
| ZA (1) | ZA959512B (zh) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN110036344A (zh) * | 2017-02-03 | 2019-07-19 | 日产化学株式会社 | 包含具有具有脲键的结构单元的聚合物的抗蚀剂下层膜形成用组合物 |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0217294D0 (en) * | 2002-07-25 | 2002-09-04 | Glaxo Group Ltd | Medicaments |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP3007138B2 (ja) * | 1990-11-27 | 2000-02-07 | ファイザー製薬株式会社 | 新規なヒドロキサム酸とｎ―ヒドロキシ尿素誘導体およびそれらの組成物 |
| US5326883A (en) * | 1992-12-18 | 1994-07-05 | Abbott Laboratories | Oxime ether derivatives having lipoxygenase inhibitory activity |
| DE69411003T2 (de) * | 1993-04-07 | 1998-10-08 | Pfizer Inc., New York, N.Y. | Cycloalkylhydroxyharnstoffe und ihre verwendung als lipoxy-genase-inhibitoren |
| TW448144B (en) * | 1993-08-19 | 2001-08-01 | Pfizer | Phenoxyphenyl cyclopentenyl hydroxyureas |
-
1995
- 1995-05-26 AT AT95918112T patent/ATE184272T1/de not_active IP Right Cessation
- 1995-05-26 DE DE69512080T patent/DE69512080T2/de not_active Expired - Fee Related
- 1995-05-26 CA CA002205033A patent/CA2205033C/en not_active Expired - Fee Related
- 1995-05-26 ES ES95918112T patent/ES2135066T3/es not_active Expired - Lifetime
- 1995-05-26 EP EP95918112A patent/EP0790981B1/en not_active Expired - Lifetime
- 1995-05-26 MX MX9703485A patent/MX9703485A/es unknown
- 1995-05-26 US US08/836,452 patent/US5798383A/en not_active Expired - Fee Related
- 1995-05-26 WO PCT/IB1995/000399 patent/WO1996015106A1/en active IP Right Grant
- 1995-10-30 MY MYPI95003267A patent/MY112595A/en unknown
- 1995-11-01 AR ARP950100014A patent/AR002239A1/es unknown
- 1995-11-02 IL IL11585395A patent/IL115853A/xx active IP Right Grant
- 1995-11-03 SG SG1995001721A patent/SG44332A1/en unknown
- 1995-11-07 PE PE1995284002A patent/PE49596A1/es not_active Application Discontinuation
- 1995-11-08 TW TW084111851A patent/TW363960B/zh active
- 1995-11-09 KR KR1019950040425A patent/KR0182321B1/ko not_active IP Right Cessation
- 1995-11-09 BR BR9505130A patent/BR9505130A/pt not_active IP Right Cessation
- 1995-11-09 PL PL95311325A patent/PL179023B1/pl unknown
- 1995-11-09 NZ NZ280434A patent/NZ280434A/en unknown
- 1995-11-09 ZA ZA959512A patent/ZA959512B/xx unknown
- 1995-11-09 AU AU37764/95A patent/AU690354B2/en not_active Ceased
- 1995-11-09 CZ CZ952942A patent/CZ282832B6/cs not_active IP Right Cessation
- 1995-11-09 NO NO954530A patent/NO305362B1/no not_active IP Right Cessation
- 1995-11-09 RU RU95119414/04A patent/RU2119479C1/ru not_active IP Right Cessation
- 1995-11-10 CO CO95053260A patent/CO4520227A1/es unknown
- 1995-11-10 TR TR95/01413A patent/TR199501413A2/xx unknown
-
1997
- 1997-05-09 FI FI971994A patent/FI113643B/fi not_active IP Right Cessation
-
1999
- 1999-09-29 GR GR990402472T patent/GR3031378T3/el unknown
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN110036344A (zh) * | 2017-02-03 | 2019-07-19 | 日产化学株式会社 | 包含具有具有脲键的结构单元的聚合物的抗蚀剂下层膜形成用组合物 |
| CN110036344B (zh) * | 2017-02-03 | 2024-04-12 | 日产化学株式会社 | 包含具有含脲键的结构单元的聚合物的抗蚀剂下层膜形成用组合物 |
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE60003001D1 (en) | Pyrimidinverbindungen | |
| AU2003225617A1 (en) | Thiadiazolylpiperazine derivatives useful for treating or preventing pain | |
| BG103518A (en) | 2-(purin-9-yl)tetrahydrofuran-3,4-diol derivatives | |
| BR0313197A (pt) | Agentes citotóxicos contendo potentes taxanos e seu uso terapêutico | |
| BRPI0513888A (pt) | composição medicinal, métodos para a profilaxia ou tratamento de uma doença autoimune, e para preparação da composição medicinal, uso de uma composição medicinal, procedimento de administração, e, agente terapêutico | |
| TW200642685A (en) | Novel spiroindoline or spiroisoquinoline compounds, methods of use and compositions thereof | |
| DK0409406T3 (da) | Arylsubstituerede aminderivater, der er anvendelige ved cancerterapi | |
| IL162614A (en) | Alpha tocopherol esters for use in treating culture-borne cell disease by aerosol administration | |
| MX9707531A (es) | Nuevos compuestos heterociclicos. | |
| EP0467856A3 (en) | Aminoalkanesulfonic acid derivatives and pharmaceutical compositions for use in preventing or treating heart diseases | |
| SG145570A1 (en) | 4-æ7-halo-2-quino(xa-)linyloxy!phenoxy-propionic acid derivatives as antineoplastic agents | |
| MY146121A (en) | Antithrombotic dual inhibitors comprising a biotin residue | |
| TW363960B (en) | Aryloxycycloalkenyl and aryloxyiminocycloalkenylhydroxyureas | |
| MY139586A (en) | Substituted 4-phenyl-4-[1h-imidazol-2-yl]-piperidine derivatives for reducing ichaemic damage | |
| ES2170758T3 (es) | Antibioticos novedosos de cefalosporina y procedimientos para la preparacion de los mismos. | |
| PL1648924T3 (pl) | Dipeptydowe inhibitory transglutaminaz i sposoby ich stosowania | |
| ES2140445T3 (es) | Derivados de pirrolidinil-tio-penem con propiedades antibioticas. | |
| ATE223907T1 (de) | Arginnin analoge mit no- syntax inhibierenderwirkung | |
| CA2232267A1 (en) | Novel imidazole lipoxygenase inhibitors | |
| MY135855A (en) | "pyrrolopyrimidinone derivatives, process of preparation and use" | |
| MX9802679A (es) | Derivados de ditiolan, su preparacion y su efecto terapeutico. |